Patents by Inventor Scott Charles Potter

Scott Charles Potter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HUMAN LAIR1 ANTIBODIES
    Publication number: 20240101670
    Abstract: The present disclosure relates to antibodies that bind human LAIR1 (“anti-human LAIR1 antibodies” or “anti-human LAIR1 antibodies”), compositions comprising such anti-human LAIR1 antibodies, and methods of using such anti-human LAIR1 antibodies.
    Type: Application
    Filed: September 15, 2023
    Publication date: March 28, 2024
    Inventors: Julian DAVIES, Scott Charles POTTER, Andrew Charles VENDEL, Wei WANG, Reid Martin Renny FELDMAN, Shireen Syrah KHAN, Monica MACAL, Maria Elena AYALA RAMIREZ
  • HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
    Publication number: 20240082414
    Abstract: The present disclosure provides human tumor necrosis factor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of autoimmune and inflammatory diseases.
    Type: Application
    Filed: May 5, 2023
    Publication date: March 14, 2024
    Inventors: Grace Chao, Joshua R Clayton, Jordan Scott Crampton, Yiqing Feng, Donmienne Doen Mun Leung, Songqing Na, Kristin Paige Newburn, Scott Charles Potter, Bharathi Ramamurthy, David John Stokell, Jacqueline M. Wurst, Jianghuai Xu
  • CD200R AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20220251198
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 11, 2022
    Inventors: Stephen J. Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta
  • CD200R agonist antibodies and uses thereof
    Patent number: 11319370
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: May 3, 2022
    Assignee: Eli Lilly and Company
    Inventors: Stephen J Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta
  • CD200R AGONIST ANTIBODIES AND USES THEREOF
    Publication number: 20200087395
    Abstract: The present invention relates to anti-human CD200R agonist antibodies, and uses thereof for treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, IBD, SLE, MS, RA, GvHD, or psoriasis.
    Type: Application
    Filed: September 11, 2019
    Publication date: March 19, 2020
    Inventors: Stephen J Demarest, Anja Koester, Scott Charles Potter, Diana Isabel Ruiz, Derrick Ryan Witcher, Xiufeng Wu, Payal Mehta